Evidence map›Paper›PMID 27283166›Full record

ArticleJournal of the National Comprehensive Cancer Network : JNCCN2016

Readability of Online Patient Educational Resources Found on NCI-Designated Cancer Center Web Sites.

Stephen A Rosenberg, David Francis, Craig R Hullett, Zachary S Morris, Michael M Fisher, Jeffrey V Brower, Kristin A Bradley, Bethany M Anderson, Michael F Bassetti, Randall J Kimple

Abstract read
In one paragraph

Article in Journal of the National Comprehensive Cancer Network : JNCCN, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Stephen A RosenbergThe Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, University of Wisconsin–Madison, Madison, Wisconsin
David FrancisThe Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, University of Wisconsin–Madison, Madison, Wisconsin
Craig R HullettThe Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, University of Wisconsin–Madison, Madison, Wisconsin
Zachary S MorrisThe Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, University of Wisconsin–Madison, Madison, Wisconsin
Michael M FisherThe Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, University of Wisconsin–Madison, Madison, Wisconsin
Jeffrey V BrowerThe Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, University of Wisconsin–Madison, Madison, Wisconsin
Kristin A BradleyThe Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, University of Wisconsin–Madison, Madison, Wisconsin
Bethany M AndersonThe Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, University of Wisconsin–Madison, Madison, Wisconsin
Michael F BassettiThe Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, University of Wisconsin–Madison, Madison, Wisconsin
Randall J KimpleThe Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, University of Wisconsin–Madison, Madison, Wisconsin

Funding

Head and Neck squamous cell carcinoma radiation response modulation by HPVR00CA160639 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI KIMPLE, RANDALL J. · 2013 to 2015
$725k
Head and Neck squamous cell carcinoma radiation response modulation by HPVK99CA160639 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI KIMPLE, RANDALL J. · 2011 to 2012
$298k
NCI NIH HHS K99 CA160639NCI NIH HHS R00 CA160639
6 · The paper itself

Abstract

backgroundThe NIH and Department of Health & Human Services recommend online patient information (OPI) be written at a sixth grade level. We used a panel of readability analyses to assess OPI from NCI-Designated Cancer Center (NCIDCC) Web sites.

methodsCancer.gov was used to identify 68 NCIDCC Web sites from which we collected both general OPI and OPI specific to breast, prostate, lung, and colon cancers. This text was analyzed by 10 commonly used readability tests: the New Dale-Chall Readability Formula, Flesch Reading Ease scale, Flesch-Kinaid Grade Level, FORCAST scale, Fry Readability Graph, Simple Measure of Gobbledygook test, Gunning Frequency of Gobbledygook index, New Fog Count, Raygor Readability Estimate Graph, and Coleman-Liau Index. We tested the hypothesis that the readability of NCIDCC OPI was written at the sixth grade level. Secondary analyses were performed to compare readability of OPI between comprehensive and noncomprehensive centers, by region, and to OPI produced by the American Cancer Society (ACS).

resultsA mean of 30,507 words from 40 comprehensive and 18 noncomprehensive NCIDCCs was analyzed (7 nonclinical and 3 without appropriate OPI were excluded). Using a composite grade level score, the mean readability score of 12.46 (ie, college level: 95% CI, 12.13-12.79) was significantly greater than the target grade level of 6 (middle-school: P<.001). No difference between comprehensive and noncomprehensive centers was identified. Regional differences were identified in 4 of the 10 readability metrics (P<.05). ACS OPI provides easier language, at the seventh to ninth grade level, across all tests (P<.01).

conclusionsOPI from NCIDCC Web sites is more complex than recommended for the average patient.

Indexed as

ComprehensionHumansInternetNational Cancer Institute (U.S.)Patient Education as TopicUnited States

Identifiers

PMID27283166
PMCPMC7236813

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.